Tetraphase Pharmaceuticals Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2020 to a ratio of 4.73, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2020. Average receivable collection period, for the Tetraphase Pharmaceuticals Inc in Mar 31 2020 quarter, has decreased to 77 days, compared to 84 days, in the Dec 31 2019 quarter.

If we take a look into Healthcare sector 425 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3000, from overall ranking in the fourth quarter 2019 at 3484.

What is Receivable Turnover Ratio?
What is Tetraphase Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TTPH Receivables Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Receivable Change	-6.16 %	-33.91 %	-34.15 %	-44.47 %	-43.42 %
Y / Y Revenue Change	37.86 %	-60.54 %	190.18 %	-90.73 %	-32.68 %
Receivable Turnover Ratio (TTM)	4.73	4.37	5.3	3.7	7.46
TTPH's Total Ranking	# 3000	# 3484	# 2839	# 3352	# 2001
Accounts Receivable average collection period days	77	84	69	99	49
Seq. Receivable Change	13.51 %	-12.11 %	-1.04 %	-4.95 %	-20.05 %
Seq. Revenue Change	3.85 %	-49.4 %	211.28 %	-15.71 %	-70.28 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 147
Healthcare Sector	# 426
Overall Market	# 3000

Receivable Turnover Ratio Statistics
High	Average	Low
7.46	3.94	2.2
(Mar 31 2019)		(Dec 31 2016)

TTPH Company Profile • Back to TTPH Efficiency Comparisons • Compare TTPH Receivables Turnover Ratio to its Competitors

Financial Statements
Tetraphase Pharmaceuticals Inc's Accounts Receivable	$ 2 Millions	Visit TTPH's Balance sheet
Tetraphase Pharmaceuticals Inc's Sales TTM	$ 8 Millions	Visit TTPH's Income Statement
Sources of TTPH's Revenues		Visit TTPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TTPH's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TTPH's Growth Rates	TTPH's Roa	TTPH's Inventory Turnover Ratio	TTPH's Dividend Comparisons
TTPH's Profitability Ratios	TTPH's Roi	TTPH's Asset Turnover Ratio	TTPH's Dividend Growth
TTPH's Valuation Ratios	TTPH's Roe	TTPH's Financial Strength Ratios	TTPH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2020	Receivable at quarter ending Mar 31 2020
1life Healthcare Inc	12.64	$ 292.004 Millions	$ 23.100 Millions
Catalyst Pharmaceuticals Inc	12.55	$ 118.994 Millions	$ 9.482 Millions
Integrated Biopharma Inc	12.47	$ 52.818 Millions	$ 4.236 Millions
Dariohealth Corp	12.45	$ 6.984 Millions	$ 0.561 Millions
Adapthealth Corp	12.20	$ 601.585 Millions	$ 49.317 Millions
Optinose Inc	11.98	$ 37.217 Millions	$ 3.108 Millions
Semler Scientific inc	11.96	$ 35.436 Millions	$ 2.962 Millions
Neptune Wellness Solutions Inc	11.86	$ 22.657 Millions	$ 1.911 Millions
Surmodics Inc	11.86	$ 100.598 Millions	$ 8.485 Millions
Lifeloc Technologies Inc	11.84	$ 8.701 Millions	$ 0.735 Millions
Cyclo Therapeutics Inc	11.54	$ 1.112 Millions	$ 0.096 Millions
China Pharma Holdings Inc	11.34	$ 9.759 Millions	$ 0.861 Millions
Ppd Inc	11.32	$ 4,139.741 Millions	$ 365.642 Millions
Patterson Companies Inc	11.25	$ 5,490.011 Millions	$ 487.932 Millions
Sunwin Stevia International Inc.	11.12	$ 26.091 Millions	$ 2.347 Millions
Insulet Corporation	11.04	$ 776.645 Millions	$ 70.352 Millions
Travere Therapeutics Inc	10.74	$ 183.537 Millions	$ 17.091 Millions
Orthofix Medical Inc	10.73	$ 455.666 Millions	$ 42.465 Millions
Rigel Pharmaceuticals Inc	10.71	$ 102.425 Millions	$ 9.564 Millions
La Jolla Pharmaceutical Company	10.69	$ 26.250 Millions	$ 2.456 Millions
Immucell Corporation	10.67	$ 14.223 Millions	$ 1.333 Millions
Scienture Holdings Inc	10.51	$ 8.127 Millions	$ 0.773 Millions
National Healthcare Corp	10.49	$ 1,004.222 Millions	$ 95.718 Millions
Teladoc Health Inc	10.48	$ 605.533 Millions	$ 57.779 Millions
Acadia Pharmaceuticals Inc	10.46	$ 366.185 Millions	$ 35.001 Millions
Pacira Biosciences inc	10.23	$ 435.397 Millions	$ 42.560 Millions
Zynex inc	10.21	$ 51.504 Millions	$ 5.044 Millions
Exact Sciences Corporation	10.19	$ 1,062.071 Millions	$ 104.204 Millions
Inovio Pharmaceuticals Inc	10.02	$ 5.632 Millions	$ 0.562 Millions
Dmk Pharmaceuticals Corporation	10.01	$ 21.871 Millions	$ 2.185 Millions

Date modified: 2026-08-29T17:23:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.